# Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

> **NCT00089141** · PHASE3 · TERMINATED · sponsor: **Martin, Paul** · enrollment: 151 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** mycophenolate mofetil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00089141
- **Lead sponsor:** Martin, Paul
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** 2008-07
- **Final completion:** 2008-09
- **Target enrollment:** 151 (ACTUAL)
- **Why stopped:** Low probability of positive outcome
- **Last updated:** 2013-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089141, "Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00089141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*